Email address
Request a Demo
Latest
Search
Popular
Community
CRO Directory
Structure Search
Quick Search
Ctrl+
K
PREMIUM
APPROVALS
RARE OR GENETIC
ONCOLOGY
5 minute read
Mar. 1, 2022
Mitapivat, Pacritinib, and Sutimlimab Among FDA Approvals in February 2022
Authors:
Vinicius Teixeira
,
Jennifer Huen
Loading...
Other articles you may be interested in